New antibiotic studied in newborns to fight tough infections
NCT ID NCT06086626
First seen Mar 12, 2026 · Last updated May 07, 2026 · Updated 6 times
Summary
This study looked at how the antibiotic cefiderocol works in hospitalized newborns under 3 months old with serious bacterial infections. Researchers measured how the drug moves through the body and checked for side effects. The goal was to find the right dose for this age group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAM-NEGATIVE BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
-
Chang Gung Memorial Hospital, Linkou Department of Pediatrics
Taoyuan City, 333, Taiwan
-
Duke University
Durham, North Carolina, 27705, United States
-
Tygerberg Hospital
Cape Town, Western Cape, 8000, South Africa
Conditions
Explore the condition pages connected to this study.